EOLS Common Stock · Transaction Dec 20, 2021 · Filed Jan 27, 2022 · Amount pending receipt enrichment
NASDAQ NMS - GLOBAL MARKET · EOLS
+0.48% · +$0.0400 · Vol 582.7K
Market closed · last close 4:00 PM ET · price as of 16:01:27 ET
Evolus Inc
Pharmaceuticals
$8.39
Veridion Score
BETAHIGH CONF · 6/6 factorsFri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET · EOLS
MethodologyEOLS
Evolus Inc
Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
STRONG
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
77/ 100
Veridion Score
STRONG · HIGH confidence
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6/6 factors with data · Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is EOLS moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Evolus Inc
PHARMACEUTICAL PREPARATIONSListed since
2018
Employees
353
Country
US
Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$8.35
Day high
$8.48
Day low
$8.23
Previous close
$8.35
52W high
$8.60
-2.44% from high
52W low
$3.94
95% of range
Market cap
$554.2M
EPS
$-0.7900
Beta
0.32
Shares out
66.1M
Volume
582.7K
0.63× rel vol
Avg volume
926.9K
VWAP
$8.37
Price history computed in-house
1W
+7.98%
1M
+40.30%
3M
+34.24%
1Y
+9.24%
YTD
+26.17%
SMA 50 $6.82 · above
SMA 200 $5.96 · above
52W position 95%
EOLS overview
Related filings and maps
Public disclosures
Congress activity in EOLS
Official filing ↗
Federal contracts
EOLS contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for EOLS in this window.
Lobbying spend
EOLS lobbying filings, year to date.
Registered lobbying filings matched to Evolus Inc.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for EOLS in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for EOLS.
Options
Sovereign unlock shows live options positioning for EOLS.